{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:58:42Z","timestamp":1780955922970,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ghir.2026.101703","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:20:43Z","timestamp":1778970043000},"page":"101703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Growth hormone deficiency following traumatic brain injury in adults: Still much of a clinical enigma"],"prefix":"10.1016","volume":"84","author":[{"given":"Kevin C.J.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ghir.2026.101703_bb0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10143-024-03088-3","article-title":"Acute and chronic hypopituitarism following traumatic brain injury: a systematic review and meta-analysis","volume":"47","author":"Aljboor","year":"2024","journal-title":"Neurosurg. Rev."},{"issue":"2","key":"10.1016\/j.ghir.2026.101703_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/neu.2018.6349","article-title":"Prevalence of anterior pituitary dysfunction twelve months or more following traumatic brain injury in adults: a systematic review and meta-analysis","volume":"37","author":"Emelifeonwu","year":"2020","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/CCM.0000000000000046","article-title":"Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review","volume":"42","author":"Lauzier","year":"2014","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.ghir.2026.101703_bb0025","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","article-title":"Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review","volume":"298","author":"Schneider","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2026.101703_bb0030","series-title":"Traumatic Brain Injury (TBI): DoD Standard Surveillance Case Definition for TBI adapted for AFHSB Use","author":"Branch AFHS","year":"2015"},{"issue":"2","key":"10.1016\/j.ghir.2026.101703_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.annemergmed.2016.11.032","article-title":"Predictive utility of the total Glasgow coma scale versus the motor component of the Glasgow coma scale for identification of patients with serious traumatic injuries","volume":"70","author":"Chou","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ghir.2026.101703_bb0040","doi-asserted-by":"crossref","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81\u201384.","DOI":"10.1016\/S0140-6736(74)91639-0"},{"key":"10.1016\/j.ghir.2026.101703_bb0045","doi-asserted-by":"crossref","unstructured":"Bodien YG, Barra A, Temkin NR, Barber J, Foreman B, Vassar M, Robertson C, Taylor SR, Markowitz AJ, Manley GT, Giacino JT, Edlow BL, Investigators T-T. Diagnosing level of consciousness: the limits of the Glasgow coma scale total score. J. Neurotrauma. 2021;38(23):3295\u20133305.","DOI":"10.1089\/neu.2021.0199"},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PEC.0b013e31827b52bf","article-title":"Predictive value of initial Glasgow coma scale score in pediatric trauma patients","volume":"29","author":"Cicero","year":"2013","journal-title":"Pediatr. Emerg. Care"},{"issue":"10","key":"10.1016\/j.ghir.2026.101703_bb0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/PEC.0b013e31826cac31","article-title":"Does a prehospital Glasgow coma scale score predict pediatric outcomes?","volume":"28","author":"Nesiama","year":"2012","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.ghir.2026.101703_bb0060","unstructured":"Manley GT, Dams-O'Connor K, Alosco ML, Awwad HO, Bazarian JJ, Bragge P, Corrigan JD, Doperalski A, Ferguson AR, Mac Donald CL, Menon DK, McNett MM, van der Naalt J, Nelson LD, Pisica D, Silverberg ND, Umoh N, Wilson L, Yuh EL, Zetterberg H, Maas AIR, McCrea MA, Classification N-NT, Nomenclature I. A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature initiative. Lancet. Neurol. 2025;24(6):512\u2013523."},{"issue":"13\u201314","key":"10.1016\/j.ghir.2026.101703_bb0065","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1089\/neu.2024.0577","article-title":"Clinical assessment on days 1-14 for the characterization of traumatic brain injury: recommendations from the 2024 NINDS traumatic brain injury Classification and Nomenclature initiative clinical\/symptoms working group","volume":"42","author":"Menon","year":"2025","journal-title":"J. Neurotrauma"},{"issue":"13\u201314","key":"10.1016\/j.ghir.2026.101703_bb0070","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1089\/neu.2025.0079","volume":"42","author":"Mac Donald","year":"2025","journal-title":"J. Neurotrauma"},{"issue":"1 Suppl 1","key":"10.1016\/j.ghir.2026.101703_bb0085","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/TA.0000000000001471","article-title":"Alterations in brain-derived neurotrophic factor and insulin-like growth factor-1 protein levels after penetrating ballistic-like brain injury in rats","volume":"83","author":"Madathil","year":"2017","journal-title":"J. Trauma Acute Care Surg."},{"issue":"13","key":"10.1016\/j.ghir.2026.101703_bb0095","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/neu.2017.5374","article-title":"Central infusion of insulin-like growth Factor-1 increases hippocampal neurogenesis and improves neurobehavioral function after traumatic brain injury","volume":"35","author":"Carlson","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12929-019-0587-9","article-title":"The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury","volume":"26","author":"Wang","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/neur.2025.0009","article-title":"IGF-1 as a biomarker for symptom severity in adult traumatic brain injury: evidence from an observational study","volume":"6","author":"Weppner","year":"2025","journal-title":"Neurotrauma Rep."},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11102-019-00956-w","article-title":"Clinical picture and the treatment of TBI-induced hypopituitarism","volume":"22","author":"Caputo","year":"2019","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.ghir.2026.101703_bb0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bjsports-2017-097791","article-title":"A systematic review of potential long-term effects of sport-related concussion","volume":"51","author":"Manley","year":"2017","journal-title":"Br. J. Sports Med."},{"issue":"11","key":"10.1016\/j.ghir.2026.101703_bb0120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/neu.2017.5257","article-title":"Divergent Classification methods of post-concussion syndrome after mild traumatic brain injury: prevalence rates, risk factors, and functional outcome","volume":"35","author":"Voormolen","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2013.11.004","article-title":"Cognitive sequelae of traumatic brain injury","volume":"37","author":"Rabinowitz","year":"2014","journal-title":"Psychiatr. Clin. North Am."},{"issue":"4","key":"10.1016\/j.ghir.2026.101703_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174847","article-title":"Mild traumatic brain injury (mTBI) and chronic cognitive impairment: a scoping review","volume":"12","author":"McInnes","year":"2017","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.ghir.2026.101703_bb0135","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11845-019-02007-6","article-title":"Hypopituitarism post traumatic brain injury (TBI): review","volume":"188","author":"Kgosidialwa","year":"2019","journal-title":"Ir. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.ghir.2026.101703_bb0140","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.02.042","article-title":"The natural history of post-traumatic hypopituitarism: implications for assessment and treatment","volume":"118","author":"Agha","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ghir.2026.101703_bb0145","doi-asserted-by":"crossref","unstructured":"Grahnen A, Kastrup K, Heinrich U, Gourmelen M, Preece MA, Vaccarello MA, Guevara-Aguirre J, Rosenfeld RG, Sietnieks A. Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency. Acta Paediatr. Suppl. 1993;82 Suppl 391:9\u201313; discussion 14.","DOI":"10.1111\/j.1651-2227.1993.tb12918.x"},{"issue":"11","key":"10.1016\/j.ghir.2026.101703_bb0150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of endocrinology guidelines for Management of Growth Hormone Deficiency in adults and patients transitioning from Pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0155","article-title":"Hypopituitarism after traumatic brain injury","volume":"11","author":"Gray","year":"2019","journal-title":"Cureus."},{"key":"10.1016\/j.ghir.2026.101703_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.634415","article-title":"Traumatic brain injury as frequent cause of hypopituitarism and growth hormone deficiency: epidemiology, diagnosis, and treatment","volume":"12","author":"Gasco","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.ghir.2026.101703_bb0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/02699050400025315","article-title":"Consensus guidelines on screening for hypopituitarism following traumatic brain injury","volume":"19","author":"Ghigo","year":"2005","journal-title":"Brain Inj."},{"issue":"2","key":"10.1016\/j.ghir.2026.101703_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11102-009-0215-x","article-title":"Pituitary function in subjects with mild traumatic brain injury: a review of literature and proposal of a screening strategy","volume":"13","author":"Tanriverdi","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0175","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1038\/s41598-021-87385-7","article-title":"Growth hormone deficiency testing and treatment following mild traumatic brain injury","volume":"11","author":"Mercier","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ghir.2026.101703_bb0180","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0363","article-title":"Pituitary dysfunction following mild traumatic brain injury in female athletes","volume":"13","author":"Eggertsdottir Claessen","year":"2024","journal-title":"Endocr. Connect."},{"issue":"17","key":"10.1016\/j.ghir.2026.101703_bb0185","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/neu.2015.4127","article-title":"Detection of growth hormone deficiency in adults with chronic traumatic brain injury","volume":"33","author":"Kreber","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101703_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2022.101495","article-title":"A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury","volume":"66","author":"Yuen","year":"2022","journal-title":"Growth Horm. IGF Res."},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12909-024-05027-8","article-title":"Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study","volume":"24","author":"Cardenas","year":"2024","journal-title":"BMC Med. Educ."},{"key":"10.1016\/j.ghir.2026.101703_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2023.101544","article-title":"Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: a pilot study","volume":"71","author":"Herodes","year":"2023","journal-title":"Growth Horm. IGF Res."},{"issue":"16","key":"10.1016\/j.ghir.2026.101703_bb0205","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/neu.2012.2752","article-title":"A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity?","volume":"30","author":"Tanriverdi","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101703_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1757-7241-21-33","article-title":"Acute neuro-endocrine profile and prediction of outcome after severe brain injury","volume":"21","author":"Olivecrona","year":"2013","journal-title":"Scand. J. Trauma Resusc. Emerg. Med."},{"issue":"6","key":"10.1016\/j.ghir.2026.101703_bb0215","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/jc.2005-2476","article-title":"High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma","volume":"91","author":"Tanriverdi","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12902-018-0247-1","article-title":"Utility of serum IGF-1 for diagnosis of growth hormone deficiency following traumatic brain injury and sport-related concussion","volume":"18","author":"Lithgow","year":"2018","journal-title":"BMC Endocr. Disord."},{"issue":"5","key":"10.1016\/j.ghir.2026.101703_bb0225","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1530\/EC-20-0117","article-title":"Traumatic brain injuries induced pituitary dysfunction: a call for algorithms","volume":"9","author":"Gilis-Januszewska","year":"2020","journal-title":"Endocr. Connect."},{"issue":"5","key":"10.1016\/j.ghir.2026.101703_bb0230","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3171\/jns.1999.91.5.0750","article-title":"Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring","volume":"91","author":"Vespa","year":"1999","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.ghir.2026.101703_bb0235","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4158\/EP14603.OR","article-title":"Trends in growth hormone stimulation testing and growth hormone dosing in adult growth hormone deficiency patients: results from the ANSWER program","volume":"22","author":"Gordon","year":"2016","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.ghir.2026.101703_bb0240","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2009-0299","article-title":"Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?","volume":"94","author":"Yuen","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101703_bb0245","unstructured":"Macrilen FDA approval history. https:\/\/wwwdrugscom\/history\/macrilenhtml.Accessed December 10, 2023."},{"issue":"8","key":"10.1016\/j.ghir.2026.101703_bb0250","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/jc.2018-00665","article-title":"Macimorelin as a diagnostic test for adult GH deficiency","volume":"103","author":"Garcia","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2026.101703_bb0255","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2013-1157","article-title":"Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency","volume":"98","author":"Garcia","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2026.101703_bb0260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1530\/EC-20-0491","article-title":"Sensitivity and specificity of the macimorelin test for diagnosis of AGHD","volume":"10","author":"Garcia","year":"2021","journal-title":"Endocr. Connect."},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0265","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-09-0824","article-title":"Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery","volume":"162","author":"Berg","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101703_bb0270","doi-asserted-by":"crossref","unstructured":"Tavares AB, Seixas-da-Silva IA, Silvestre DH, Paixao CM, Jr., Vaisman M, Conceicao FL. Potential risks of glucagon stimulation test in elderly people. Growth Horm. IGF Res. 2015;25(1):53\u201356.","DOI":"10.1016\/j.ghir.2014.11.002"},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4158\/EP11146.OR","article-title":"Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests","volume":"18","author":"Toogood","year":"2012","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.ghir.2026.101703_bb0280","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11102-012-0407-7","article-title":"Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults","volume":"16","author":"Yuen","year":"2013","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.ghir.2026.101703_bb0285","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1210\/jc.2014-2830","article-title":"Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency","volume":"99","author":"Dichtel","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2026.101703_bb0290","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11102-015-0666-1","article-title":"Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?","volume":"18","author":"Diri","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2026.101703_bb0295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ghir.2015.12.005","article-title":"Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease","volume":"26","author":"Wilson","year":"2016","journal-title":"Growth Horm. IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0300","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11102-016-0712-7","article-title":"Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study","volume":"19","author":"Hamrahian","year":"2016","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ghir.2026.101703_bb0305","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2265.2004.02023.x","article-title":"Neuroendocrine dysfunction in the acute phase of traumatic brain injury","volume":"60","author":"Agha","year":"2004","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"10.1016\/j.ghir.2026.101703_bb0310","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/er.2014-1065","article-title":"Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach","volume":"36","author":"Tanriverdi","year":"2015","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.ghir.2026.101703_bb0315","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/jnnp-2016-315500","article-title":"The screening and management of pituitary dysfunction following traumatic brain injury in adults: British neurotrauma group guidance","volume":"88","author":"Tan","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.ghir.2026.101703_bb0320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/neu.2024.0114","article-title":"Identifying growth hormone deficiency in brain-injured patients: the quality of life Scale-99","volume":"42","author":"Barnard","year":"2025","journal-title":"J. Neurotrauma"},{"issue":"5","key":"10.1016\/j.ghir.2026.101703_bb0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11102-024-01433-9","article-title":"Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study","volume":"27","author":"Zacharia","year":"2024","journal-title":"Pituitary"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:12:40Z","timestamp":1780953160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637426000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S1096637426000250"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101703","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone deficiency following traumatic brain injury in adults: Still much of a clinical enigma","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101703"}}